Thalidomide for refractory hemorrhagic chronic radiation proctitis secondary to pelvic malignancy radiotherapy: A phase II clinical trial

Figure 1  Flow chart of patient selection.

Figure 2 The efficacy of thalidomide on hemorrhagic chronic radiation proctitis as measured by the Subjective Objective Management Analysis system score. SOMA: Subjective Objective Management Analysis system.

Figure 3 Representative endoscopic images before and after thalidomide treatment. A: Vienna Rectoscopy Score (VRS) decreased, telangiectasia score decreased; B: VRS and telangiectasia score unchanged, mucosal congestion score decreased; C: VRS, mucosal congestion score and telangiectasia score unchanged.